Virtual-reality education for patients undergoing transfemoral TAVI
Official title: VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease - A Randomized-Controlled Multicenter Study
Run by Heinrich-Heine University, Duesseldorf · NCT05552352 · Data updated 2026-11-12
This trial will see if virtual-reality patient education helps adults with severe aortic stenosis who are having elective transfemoral TAVI understand the procedure better and have fewer postprocedural complications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Heinrich-Heine University, Duesseldorf Academic / other |
| Locations | 2 sites (Düsseldorf, North Rhine-Westphalia and 1 other locations) |
| Status | Recruiting |
| Started | October 5, 2022 |
| Main results expected | August 31, 2026 |
| Study ends | February 28, 2027 |
| Registry record updated | August 28, 2025 |
| Trial ID | NCT05552352 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with high-grade aortic stenosis scheduled for elective transfemoral TAVI under conscious analgesia who can provide informed consent and use the VR equipment are ideal candidates.
✕Probably not a fit
Patients planned for general anesthesia, with severe hearing or vision impairment that prevents VR use, significant dementia, or insufficient language skills to follow the VR modules are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, randomized-controlled multicenter trial will randomize adults scheduled for elective transfemoral TAVI to receive virtual-reality (VR)–assisted education versus standard information. The VR program combines auditory, visual, written, and haptic modules to familiarize patients with the procedure, the care environment, and safety aspects. Investigators hypothesize that improved understanding and simulated orientation will reduce pre- and peri-procedural anxiety, disorientation, pain, and the risk of delirium, thereby lowering postprocedural complications. The primary outcome is expected to be length of hospital stay, with secondary outcomes including patient knowledge, anxiety scores, delirium incidence, and complication rates.
Why it matters
Potential benefit: If successful, patients could experience less anxiety and fewer complications after transfemoral TAVI, leading to shorter hospital stays.
How similar studies have gone: Other surgical and procedural settings have shown that VR education can reduce preprocedural anxiety and improve patient knowledge, but evidence specific to TAVI patients is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * High-grade aortic valve stenosis * Indication for elective transfemoral transcatheter aortic valve implantation under analgesia (TAVI) * Existing heart center decision * Age ≥ 18 years * Signed informed consent form Exclusion Criteria: * Surgery planned under general anesthesia * Language barrier, defined as insufficient language proficiency at the discretion of the investigator to understand the purpose of the trial and follow the VR application. * Severe hearing impairment, preventing the patient from understanding the sound of the VR goggles, tested with the VR goggles fitted without using the VRAP-Heart software * Severe visual impairment that prevents viewing of the VR modules if it is not possible to use existing visual corrections (contact lenses, glasses) together with the VR glasses in the event of defective vision, tested with the VR goggles fitted without using the VRAP-Heart software * Moderately severe or severe dementia syndrome noted in the medical history or identified during the informed consent discussion * Known seizure disorder (epilepsy) * Positive pregnancy test on inclusion and/or pregnancy is present * Court ordered placement in an institution * Any psychosocial condition that makes compliance with the protocol unlikely
Where it's running
-
Universitätsklinikum Düsseldorf, Klinik für Kardiologie, Pneumologie & Angiologie
Düsseldorf, North Rhine-Westphalia, Germany Recruiting -
Universitätsklinikum Köln, Klinik III für Innere Medizin, Herzzentrum, Kerpener Straße 62
Cologne, Germany Recruiting
Study contacts
- Principal investigator: Christian Jung, Prof MD PhD — Heinrich-Heine University, Duesseldorf
- Study coordinator: Christian Jung, Prof MD PhD
- Email: christian.jung@med.uni-duesseldorf.de
- Phone: +49 211 81
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hydra THV Transfemoral Valve Implantation in Severe Aortic Stenosis
This registry tests how safely and effectively the Hydra THV works when implanted through the femoral artery in adults with severe symptomatic aortic stenosis.
-
Noninvasive ECG Monitoring to Support Early Discharge After TAVI for Conduction Disorders
A noninvasive ECG monitoring approach is tested to see if it safely allows patients with conduction issues after TAVI to go home earlier.
-
FAPI-PET imaging to see heart tissue changes after TAVI for aortic stenosis
Using FAPI-PET scans, doctors will see if heart scarring and function improve after TAVI in people with severe aortic stenosis compared with those treated with medication alone.
-
Registry for patients with severe aortic valve stenosis undergoing TAVR with Myval valve
This study is testing how often heart rhythm problems happen and if patients need a pacemaker after getting a new heart valve through TAVR using the Myval valve.
-
Comparing heart valve prostheses for treating aortic stenosis
This study is testing how well different types of heart valve replacements work for people with severe aortic stenosis, especially those with smaller heart openings.
-
Personalized antithrombotic therapy for patients after aortic valve replacement
This study is testing if a personalized blood-thinning treatment can help people who have had aortic valve replacement feel better and avoid complications compared to standard treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.